SCHEMBL2349178

SCHEMBL2349178

CCCCC(C)(CCCC)CC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.48
FFAR1 O14842 2/20 0.48
CPT2 P23786 1/20 0.48
HMGCR P04035 1/20 0.44
CHRM1 P11229 1/20 0.44
TBXA2R P21731 1/20 0.44
ADRA1A P35348 1/20 0.44
TSHR P16473 5/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
HIF1A Q16665 1/20 0.42
AKR1B1 P15121 1/20 0.42
HSPD1 P10809 1/20 0.42
BLM P54132 1/20 0.42
HSPE1 P61604 1/20 0.42
PPARG P37231 6/20 0.41
PPARD Q03181 6/20 0.41
PPARA Q07869 6/20 0.41
GPR84 Q9NQS5 5/20 0.41
HDAC11 Q96DB2 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15237487 0.96 TDP1 (0.45) TDP1FFAR1CPT2HMGCRCHRM1
SCHEMBL31021331 0.95 TDP1 (0.48) TDP1FFAR1CPT2HMGCRCHRM1
SCHEMBL20076430 0.94 TDP1 (0.54) TDP1FFAR1CPT2TSHRHSPD1
SCHEMBL10776763 0.93 TDP1 (0.52) TDP1FFAR1CPT2TSHRAKR1B1
SCHEMBL18852720 0.91 TDP1 (0.56) TDP1FFAR1CPT2TSHRHSPD1
SCHEMBL22877776 0.91 TDP1 (0.56) TDP1FFAR1CPT2TSHRHSPD1
SCHEMBL19658046 0.91 TDP1 (0.56) TDP1FFAR1CPT2TSHRHSPD1
SCHEMBL19861311 0.91 TDP1 (0.56) TDP1FFAR1CPT2TSHRHSPD1
SCHEMBL2348425 0.91 TDP1 (0.56) TDP1FFAR1CPT2TSHRHSPD1
SCHEMBL11799928 0.91 TDP1 (0.45) TDP1FFAR1CPT2HMGCRCHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078724-B1 PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES ASAHI CHEMICAL IND (JP) 2016-11-30 EP disclosed
US-8741544-B2 Salt, photoresist composition and method for producing photoresist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-06-03 US disclosed
CN-101522697-B Process for production of dialkyltin dialkoxides ASAHI KASEI CHEMICALS CORP (JP) 2013-05-29 CN disclosed
US-20130052588-A1 SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-02-28 US disclosed
US-8008518-B2 Process for producing dialkyl tin dialkoxides ASAHI KASEI CHEMICALS CORPORATION (JP) 2011-08-30 US disclosed
US-20100041908-A1 PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES ASAHI KASEI KABUSHIKI KAISHA (JP) 2010-02-18 US disclosed
EP-2078724-A1 PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES Asahi Kasei Chemicals Corporation (JP) 2009-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041908-A1 PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES DEK, DDT, DERA TDP1 2846/4885FFAR1 2261/4885CPT2 2843/4885
US-20130052588-A1 SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN RER1, COL1A1, H1-0 TDP1 1809/4885FFAR1 1421/4885CPT2 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.